Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer

被引：0
|
作者：
W Chua
D Goldstein
C K Lee
H Dhillon
M Michael
P Mitchell
S J Clarke
B Iacopetta
机构：
[1] Sydney Cancer Centre,Department of Medical Oncology
[2] Concord Repatriation General Hospital,Department of Medical Oncology
[3] Prince of Wales Hospital,Division of Haematology and Medical Oncology
[4] NHMRC Clinical Trials Centre,Department of Medical Oncology
[5] Centre of Medical Psychology and Evidence-based Decision-Making,undefined
[6] University of Sydney,undefined
[7] Peter MacCallum Cancer Centre,undefined
[8] Austin Hospital,undefined
[9] School of Surgery,undefined
[10] University of Western Australia,undefined
来源：
British Journal of Cancer | 2009年 / 101卷
关键词：
colorectal cancer; metastatic; chemotherapy; predictive factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：998 / 1004
页数：6
相关论文
共 50 条
  • [21] Treatment dilemmas of cetuximab combined with chemotherapy for metastatic colorectal cancer
    Wen, Feng
    Li, Qiu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (23) : 5332 - 5341
  • [22] Markers of metastatic colorectal cancer
    Mysliwiec, Piotr
    Choromanska, Barbara
    Dadan, Jacek
    GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2020, 15 (02): : 94 - 97
  • [23] Treatment dilemmas of cetuximab combined with chemotherapy for metastatic colorectal cancer
    Feng Wen
    Qiu Li
    World Journal of Gastroenterology, 2016, (23) : 5332 - 5341
  • [24] Clinical significance of changes in systemic inflammatory markers and carcinoembryonic antigen levels in predicting metastatic colorectal cancer prognosis and chemotherapy response
    Kim, In-Ho
    Lee, Ji Eun
    Yang, Ji Hyun
    Jeong, Joon Won
    Ro, Sangmi
    Lee, Myung Ah
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 (03) : 239 - 246
  • [25] Response to FOLFOX chemotherapy in patients with colorectal cancer according to RRM2 expression
    Yan, Chongxian
    Fang, Zejun
    Liu, Hong
    Shao, Jianli
    Wang, Anhua
    Sun, Long
    Zhu, Zhihua
    Luo, Shuchai
    Chen, Xiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (11): : 21970 - 21978
  • [26] Clinical features of interstitial lung disease induced by standard chemotherapy (FOLFOX or FOLFIRI) for colorectal cancer
    Shimura, T.
    Fuse, N.
    Yoshino, T.
    Minashi, K.
    Tahara, M.
    Doi, T.
    Joh, T.
    Ohtsu, A.
    ANNALS OF ONCOLOGY, 2010, 21 (10) : 2005 - 2010
  • [27] Chemotherapy of metastatic colorectal cancer
    Saad E.D.
    Hoff P.M.
    Current Treatment Options in Gastroenterology, 2005, 8 (3) : 239 - 247
  • [28] Phenytoin toxicity in a patient receiving 5-fluorouracil-based chemotherapy for metastatic colorectal cancer
    Kuruvilla, Sara M.
    Mukherjee, Som D.
    CURRENT ONCOLOGY, 2011, 18 (06) : 264 - 265
  • [29] Chemotherapy in metastatic colorectal cancer
    Christopoulou A.
    Techniques in Coloproctology, 2004, 8 (Suppl 1) : S43 - S46
  • [30] Stop and Go FOLFOX plus Bevacizumab Chemotherapy in the First-Line Treatment of Metastatic Colorectal Cancer
    Vaidyanathan, Gayatri
    Groman, Adrienne
    Wilding, Gregory
    Fakih, Marwan G.
    ONCOLOGY, 2010, 79 (1-2) : 67 - 71
12345